Creoptix launches waveRAPID[®] – a new and faster way of measuring kinetics to accelerate drug discovery
Wädenswil/Zurich, Switzerland, 2 February 2021 – Creoptix AG , a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the launch of waveRAPID[®] (Repeated Analyte Pulses of Increasing Duration), a novel, label-free kinetic measurement method that is faster than traditional kinetics.The company developed and commercializes the Creoptix[®] WAVEsystem to enable molecular interactions to be studied in real time, helping to revolutionize drug